Trial Profile
NAVX-010 - A Phase I, Double-Blind, Placebo-Controlled, Single-Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Gonyautoxin (Primary)
- Indications Fissure in ano
- Focus Adverse reactions
- Sponsors Algenis
- 07 Sep 2018 New trial record